ALB and Ascites: Promising data derived from the ANSWER study, a randomized clinical trial in cirrhotic patients with grade 2 or 3 ascites, which tested the efficacy of chronic albumin supplementation (40 g twice weekly for 2 weeks, and then 40 g for up to 18 months) on top of the standard of care.